These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18708356)

  • 1. Small ubiquitin-related modifier (SUMO) binding determines substrate recognition and paralog-selective SUMO modification.
    Zhu J; Zhu S; Guzzo CM; Ellis NA; Sung KS; Choi CY; Matunis MJ
    J Biol Chem; 2008 Oct; 283(43):29405-15. PubMed ID: 18708356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
    Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
    Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
    Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
    Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO-2/3 modification and binding regulate the association of CENP-E with kinetochores and progression through mitosis.
    Zhang XD; Goeres J; Zhang H; Yen TJ; Porter AC; Matunis MJ
    Mol Cell; 2008 Mar; 29(6):729-41. PubMed ID: 18374647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent modification of the Werner's syndrome gene product with the ubiquitin-related protein, SUMO-1.
    Kawabe Y; Seki M; Seki T; Wang WS; Imamura O; Furuichi Y; Saitoh H; Enomoto T
    J Biol Chem; 2000 Jul; 275(28):20963-6. PubMed ID: 10806190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
    Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
    J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo identification of human small ubiquitin-like modifier polymerization sites by high accuracy mass spectrometry and an in vitro to in vivo strategy.
    Matic I; van Hagen M; Schimmel J; Macek B; Ogg SC; Tatham MH; Hay RT; Lamond AI; Mann M; Vertegaal ACO
    Mol Cell Proteomics; 2008 Jan; 7(1):132-44. PubMed ID: 17938407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification.
    Sampson DA; Wang M; Matunis MJ
    J Biol Chem; 2001 Jun; 276(24):21664-9. PubMed ID: 11259410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMOylation regulates polo-like kinase 1-interacting checkpoint helicase (PICH) during mitosis.
    Sridharan V; Park H; Ryu H; Azuma Y
    J Biol Chem; 2015 Feb; 290(6):3269-76. PubMed ID: 25564610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity.
    Stindt MH; Carter S; Vigneron AM; Ryan KM; Vousden KH
    Cell Cycle; 2011 Sep; 10(18):3176-88. PubMed ID: 21900752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.
    Gilbreth RN; Truong K; Madu I; Koide A; Wojcik JB; Li NS; Piccirilli JA; Chen Y; Koide S
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7751-6. PubMed ID: 21518904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.
    Cuijpers SAG; Willemstein E; Vertegaal ACO
    Mol Cell Proteomics; 2017 Dec; 16(12):2281-2295. PubMed ID: 28951443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1.
    Desterro JM; Rodriguez MS; Kemp GD; Hay RT
    J Biol Chem; 1999 Apr; 274(15):10618-24. PubMed ID: 10187858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small ubiquitin-related modifiers in chains.
    Vertegaal AC
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1422-3. PubMed ID: 18031236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish.
    Yuan H; Zhou J; Deng M; Liu X; Le Bras M; de The H; Chen SJ; Chen Z; Liu TX; Zhu J
    Cell Res; 2010 Feb; 20(2):185-96. PubMed ID: 19704416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
    Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins.
    Su HL; Li SS
    Gene; 2002 Aug; 296(1-2):65-73. PubMed ID: 12383504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.